
GC70973
HP210
Also known as 4-[(4-oxo-2-sulfanylidene-1H-thieno[3,2-d]pyrimidin-3-yl)methyl]-N-(1-phenylethyl)benzamide
HP210 is a selective glucocorticoid receptor modulator (SGRM)
ChemicalCAS728039-52-9MW421.54FormulaC22H19N3O2S2
- CAS number
- 728039-52-9
- Molecular weight
- 421.54
- Formula
- C22H19N3O2S2
- Solubility
- DMSO : 125 mg/mL (296·53 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
- InChIKey
- AJJBGZJAGZSMJI-UHFFFAOYSA-N
- Catalogue number
- GC70973
- Brand
- GLPBIO
Computed properties PubChem CID 4362044 · XLogP 3.9 · TPSA 122 Ų · H-bond donors 2
- XLogP
- 3.9
- TPSA
- 122 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Rotatable bonds
- 5
- Heavy atoms
- 29
SMILES CC(C1=CC=CC=C1)NC(=O)C2=CC=C(C=C2)CN3C(=O)C4=C(C=CS4)NC3=S
Computed descriptors from PubChem (CID 4362044), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il